{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:40:25Z","timestamp":1779885625179,"version":"3.53.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["1S34622N"],"award-info":[{"award-number":["1S34622N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2008625"],"award-info":[{"award-number":["APP2008625"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G024423N"],"award-info":[{"award-number":["G024423N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SC3722N"],"award-info":[{"award-number":["1SC3722N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ghent University Industrial Research Fund","award":["F2020\/IOF-StarTT\/103"],"award-info":[{"award-number":["F2020\/IOF-StarTT\/103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-02983-z","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T17:01:43Z","timestamp":1728752503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro"],"prefix":"10.1186","volume":"25","author":[{"given":"Ellen","family":"Goeteyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boll\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Joossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Van Braeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint B.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Crabb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2983_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. J Cyst Fibros. 2015;14:419\u201330.","journal-title":"J Cyst Fibros"},{"key":"2983_CR2","doi-asserted-by":"crossref","unstructured":"Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54.","DOI":"10.1183\/13993003.00651-2019"},{"key":"2983_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-0041-1730891","volume":"42","author":"HR Keir","year":"2021","unstructured":"Keir HR, Chalmers JD. Pathophysiology of Bronchiectasis. Semin Respir Crit Care Med. 2021;42:499\u2013512.","journal-title":"Semin Respir Crit Care Med"},{"key":"2983_CR4","doi-asserted-by":"publisher","first-page":"114112","DOI":"10.1016\/j.bcp.2020.114112","volume":"179","author":"A C\u00f4t\u00e9","year":"2020","unstructured":"C\u00f4t\u00e9 A, Godbout K, Boulet LP. The management of severe asthma in 2020. Biochem Pharmacol. 2020;179:114112.","journal-title":"Biochem Pharmacol"},{"key":"2983_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/mi.2016.108","volume":"10","author":"GB Huffnagle","year":"2017","unstructured":"Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017;10:299\u2013306.","journal-title":"Mucosal Immunol"},{"key":"2983_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clim.2015.05.022","volume":"159","author":"GB Huffnagle","year":"2015","unstructured":"Huffnagle GB, Dickson RP. The bacterial microbiota in inflammatory lung diseases. Clin Immunol. 2015;159:177\u201382.","journal-title":"Clin Immunol"},{"key":"2983_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41590-019-0451-9","volume":"20","author":"TP Wypych","year":"2019","unstructured":"Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20:1279\u201390.","journal-title":"Nat Immunol"},{"key":"2983_CR8","doi-asserted-by":"crossref","unstructured":"N\u2019Guessan PD, Haarmann H, Steiner T, Heyl K, Schreiber F, Heinrich A, et al. The Moraxella catarrhalis-induced pro-inflammatory immune response is enhanced by the activation of the epidermal growth factor receptor in human pulmonary epithelial cells. Biochem Biophys Res Commun. 2014;450:1038\u201344.","DOI":"10.1016\/j.bbrc.2014.06.102"},{"key":"2983_CR9","doi-asserted-by":"crossref","unstructured":"Hansen CR, Pressler T, Nielsen KG, Jensen P\u00d8, Bjarnsholt T, H\u00f8iby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros. 2010;9:51\u20138.","DOI":"10.1016\/j.jcf.2009.10.005"},{"issue":"10","key":"2983_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrmicro2801","volume":"107","author":"MR Edwards","year":"2012","unstructured":"Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol. 2012;107(10):459\u201371. (2012).","journal-title":"Nat Rev Microbiol"},{"key":"2983_CR11","doi-asserted-by":"publisher","first-page":"e1004923","DOI":"10.1371\/journal.ppat.1004923","volume":"11","author":"RP Dickson","year":"2015","unstructured":"Dickson RP, Huffnagle GB. The Lung Microbiome: New principles for respiratory bacteriology in Health and Disease. PLoS Pathog. 2015;11:e1004923.","journal-title":"PLoS Pathog"},{"key":"2983_CR12","doi-asserted-by":"crossref","unstructured":"Man WH, De Steenhuijsen Piters WAA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15.","DOI":"10.1038\/nrmicro.2017.14"},{"key":"2983_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1164\/rccm.202110-2241OC","volume":"206","author":"SS Madapoosi","year":"2022","unstructured":"Madapoosi SS, et al. Lung microbiota and metabolites collectively associate with clinical outcomes in milder Stage Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022;206:427\u201339.","journal-title":"Am J Respir Crit Care Med"},{"key":"2983_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/mi.2013.93","volume":"7","author":"M Vissers","year":"2014","unstructured":"Vissers M, De Groot R, Ferwerda G. Severe viral respiratory infections: are bugs bugging? Mucosal Immunol. 2014;7:227\u201338.","journal-title":"Mucosal Immunol"},{"key":"2983_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(14)61136-3","volume":"384","author":"RP Dickson","year":"2014","unstructured":"Dickson RP, Martinez FJ, Huffnagle GB. The role of the Microbiome in exacerbations of Chronic Lung diseases. Lancet. 2014;384:691.","journal-title":"Lancet"},{"key":"2983_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","volume":"147","author":"AJ Dicker","year":"2021","unstructured":"Dicker AJ, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147:158\u201367.","journal-title":"J Allergy Clin Immunol"},{"key":"2983_CR17","doi-asserted-by":"publisher","first-page":"1176044","DOI":"10.3389\/fimmu.2023.1176044","volume":"14","author":"E Goeteyn","year":"2023","unstructured":"Goeteyn E, et al. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front Immunol. 2023;14:1176044.","journal-title":"Front Immunol"},{"key":"2983_CR18","doi-asserted-by":"crossref","unstructured":"Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, , et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur Respir J. 2021;59.","DOI":"10.1183\/13993003.01293-2021"},{"key":"2983_CR19","doi-asserted-by":"crossref","unstructured":"Tony-Odigie A, Wilke L, Boutin S, Dalpke AH, Yi B. Commensal Bacteria in the cystic fibrosis airway microbiome reduce P. aeruginosa induced inflammation. Front Cell Infect Microbiol. 2022;12:824101.","DOI":"10.3389\/fcimb.2022.824101"},{"key":"2983_CR20","doi-asserted-by":"publisher","first-page":"e0235803","DOI":"10.1371\/journal.pone.0235803","volume":"15","author":"A Bertelsen","year":"2020","unstructured":"Bertelsen A, Elborn SJ, Schock BC. Toll like receptor signalling by Prevotella histicola activates alternative NF-\u03baB signalling in cystic fibrosis bronchial epithelial cells compared to P. aeruginosa. PLoS ONE. 2020;15:e0235803.","journal-title":"PLoS ONE"},{"key":"2983_CR21","doi-asserted-by":"crossref","unstructured":"Gupta S et al. Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing. Commun. Biol. 2019 21 2, 1\u20137 (2019).","DOI":"10.1038\/s42003-019-0540-1"},{"key":"2983_CR22","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1128\/JCM.01678-14","volume":"52","author":"I Toma","year":"2014","unstructured":"Toma I, et al. Single-molecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia. J Clin Microbiol. 2014;52:3913\u201321.","journal-title":"J Clin Microbiol"},{"key":"2983_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","volume":"390","author":"PG Gibson","year":"2017","unstructured":"Gibson PG, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2017;390:659\u201368.","journal-title":"Lancet (London England)"},{"key":"2983_CR24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","volume":"309","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, et al. Effect of Long-term, low-dose erythromycin on Pulmonary exacerbations among patients with non\u2013cystic fibrosis bronchiectasis: the BLESS Randomized Controlled Trial. JAMA. 2013;309:1260\u20137.","journal-title":"JAMA"},{"key":"2983_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","volume":"9","author":"AJ Dicker","year":"2021","unstructured":"Dicker AJ, et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021;9:885\u201396.","journal-title":"Lancet Respir Med"},{"key":"2983_CR26","doi-asserted-by":"crossref","unstructured":"Taylor SL, Leong LE, Mobegi FM, Choo JM, Wesselingh S, Yang IA, et al. Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma. Am J Respir Crit Care Med. 2019;200:309\u201317.","DOI":"10.1164\/rccm.201809-1739OC"},{"key":"2983_CR27","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","volume":"2","author":"GB Rogers","year":"2014","unstructured":"Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir Med. 2014;2:988\u201396.","journal-title":"Lancet Respir Med"},{"key":"2983_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrmicro2423","volume":"8","author":"J Barrila","year":"2010","unstructured":"Barrila J, et al. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol. 2010;8:791\u2013801.","journal-title":"Nat Rev Microbiol"},{"key":"2983_CR29","doi-asserted-by":"crossref","unstructured":"Carterson AJ, Honer zu Bentrup K, Ott CM, Clarke MS, Pierson DL, et al. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun. 2005;73:1129\u201340.","DOI":"10.1128\/IAI.73.2.1129-1140.2005"},{"key":"2983_CR30","doi-asserted-by":"crossref","unstructured":"Crabb\u00e9 A, Liu Y, Matthijs N, Rigole P, De La Fuente-N\u00f9\u00f1ez C, Davis R, et al. Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum. Sci Rep. 2017;7:1\u201313.","DOI":"10.1038\/srep43321"},{"key":"2983_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.00494","volume":"10","author":"S Van den Bossche","year":"2020","unstructured":"Van den Bossche S, Vandeplassche E, Ostyn L, Coenye T, Crabb\u00e9 A. Bacterial interference with Lactate Dehydrogenase Assay leads to an underestimation of Cytotoxicity. Front Cell Infect Microbiol. 2020;10:1\u201311.","journal-title":"Front Cell Infect Microbiol"},{"key":"2983_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-4939-2074-7_27","volume":"1250","author":"M Maes","year":"2015","unstructured":"Maes M, et al. Measurement of apoptotic and necrotic cell death in primary hepatocyte cultures. Methods Mol Biol. 2015;1250:349\u201361.","journal-title":"Methods Mol Biol"},{"key":"2983_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tiv.2016.12.004","volume":"39","author":"M Vinken","year":"2017","unstructured":"Vinken M, Blaauboer BJ. In vitro testing of basal cytotoxicity: establishment of an adverse outcome pathway from chemical insult to cell death. Toxicol in Vitro. 2017;39:104\u201310.","journal-title":"Toxicol in Vitro"},{"key":"2983_CR34","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.","journal-title":"Genome Biol"},{"key":"2983_CR35","first-page":"604","volume":"20","author":"M Jafari","year":"2019","unstructured":"Jafari M, Ansari-Pour N. Why, when and how to adjust your P values? Cell J. 2019;20:604\u20137.","journal-title":"Cell J"},{"key":"2983_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jcf.2021.04.012","volume":"20","author":"A Bertelsen","year":"2021","unstructured":"Bertelsen A, Elborn JS, Schock BC. Microbial interaction: Prevotella spp. reduce P. aeruginosa induced inflammation in cystic fibrosis bronchial epithelial cells. J Cyst Fibros. 2021;20:682\u201391.","journal-title":"J Cyst Fibros"},{"key":"2983_CR37","doi-asserted-by":"crossref","unstructured":"Li L, Mac Aogain M, Xu T, Jaggi TK, Chan LL, Qu J, et al. Neisseria species as pathobionts in bronchiectasis. Cell Host Microbe. 2022;30:1311\u201327.","DOI":"10.1016\/j.chom.2022.08.005"},{"key":"2983_CR38","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1034\/j.1399-3003.2000.01512.x","volume":"15","author":"C Nordenh\u00e4ll","year":"2000","unstructured":"Nordenh\u00e4ll C, et al. Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum. Eur Respir J. 2000;15:1046.","journal-title":"Eur Respir J"},{"key":"2983_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/COPD.S284938","volume":"16","author":"F Pedersen","year":"2021","unstructured":"Pedersen F, et al. Influence of cell quality on inflammatory biomarkers in COPD Sputum Supernatant. Int J Chron Obstruct Pulmon Dis. 2021;16:487\u201393.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2983_CR40","doi-asserted-by":"crossref","unstructured":"N\u00f8rskov-Lauritsen N. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev. 2014;27:214\u201340.","DOI":"10.1128\/CMR.00103-13"},{"key":"2983_CR41","doi-asserted-by":"crossref","unstructured":"Murra M, et al. Whole-genome sequencing of Aggregatibacter species isolated from human clinical specimens and description of Aggregatibacter Kilianii sp. nov. J Clin Microbiol. 2018;56\u20131128.","DOI":"10.1128\/JCM.00053-18"},{"key":"2983_CR42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2020.03.028","volume":"146","author":"J Durack","year":"2020","unstructured":"Durack J, et al. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. J Allergy Clin Immunol. 2020;146:1016\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"2983_CR43","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","volume":"203","author":"Z Wang","year":"2021","unstructured":"Wang Z, et al. Inflammatory endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and exacerbations a Multicohort Longitudinal Analysis. Am J Respir Crit Care Med. 2021;203:1488\u2013502.","journal-title":"Am J Respir Crit Care Med"},{"key":"2983_CR44","doi-asserted-by":"publisher","first-page":"105095","DOI":"10.1016\/j.phrs.2020.105095","volume":"160","author":"H Liu","year":"2020","unstructured":"Liu H, et al. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD. Pharmacol Res. 2020;160:105095.","journal-title":"Pharmacol Res"},{"key":"2983_CR45","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1038\/s41598-023-32901-0","volume":"13","author":"Q Xue","year":"2023","unstructured":"Xue Q, et al. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study. Sci Rep. 2023;13:5715.","journal-title":"Sci Rep"},{"key":"2983_CR46","first-page":"2047","volume":"9","author":"D Huang","year":"2019","unstructured":"Huang D, et al. The characterization of lung microbiome in lung cancer patients with different clinicopathology. Am J Cancer Res. 2019;9:2047.","journal-title":"Am J Cancer Res"},{"key":"2983_CR47","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.12659\/MSM.915332","volume":"25","author":"K Wang","year":"2019","unstructured":"Wang K, et al. A preliminary study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from patients with primary bronchogenic carcinoma. Med Sci Monit. 2019;25:2819\u201334.","journal-title":"Med Sci Monit"},{"key":"2983_CR48","first-page":"1775","volume":"8","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res. 2018;8:1775.","journal-title":"Am J Cancer Res"},{"key":"2983_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/IDR.S394779","volume":"16","author":"Q Xiao","year":"2023","unstructured":"Xiao Q, et al. Characterization of the microbiome and host\u2019s metabolites of the Lower Respiratory Tract during Acute Community-Acquired Pneumonia identifies potential novel markers. Infect Drug Resist. 2023;16:581\u201394.","journal-title":"Infect Drug Resist"},{"key":"2983_CR50","doi-asserted-by":"publisher","first-page":"e54574","DOI":"10.1371\/journal.pone.0054574","volume":"8","author":"MK Cheung","year":"2013","unstructured":"Cheung MK, et al. Sputum Microbiota in Tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS ONE. 2013;8:e54574.","journal-title":"PLoS ONE"},{"key":"2983_CR51","doi-asserted-by":"crossref","unstructured":"Ramsey MM, Whiteley M. Polymicrobial interactions stimulate resistance to host innate immunity through metabolite perception. Proc. Natl. Acad. Sci. U. S. A. 106, 1578\u20131583 (2009).","DOI":"10.1073\/pnas.0809533106"},{"key":"2983_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jmii.2013.12.007","volume":"49","author":"S Maraki","year":"2016","unstructured":"Maraki S, Papadakis IS, Chronakis E, Panagopoulos D, Vakis A. Aggregatibacter aphrophilus brain abscess secondary to primary tooth extraction: case report and literature review. J Microbiol Immunol Infect. 2016;49:119\u201322.","journal-title":"J Microbiol Immunol Infect"},{"key":"2983_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/INF.0000000000000493","volume":"34","author":"S Shilo","year":"2015","unstructured":"Shilo S, Kassis I, Hakim F, Shachor-Meyouhas Y. Aggregatibacter actinomycemcomitans pneumonia in children: two case reports and a review of the literature. Pediatr Infect Dis J. 2015;34:100\u20132.","journal-title":"Pediatr Infect Dis J"},{"key":"2983_CR54","doi-asserted-by":"crossref","unstructured":"Hagiwara SI, Fujimaru T, Ogino A, Takano T, Sekijima T, Kagimoto S, et al. Lung abscess caused by infection of Actinobacillus actinomycetemcomitans. Pediatr Int. 2009;51:748\u201351.","DOI":"10.1111\/j.1442-200X.2009.02899.x"},{"key":"2983_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/00365549509019023","volume":"27","author":"AC Chen","year":"1995","unstructured":"Chen AC, Liu CC, Yao WJ, Chen CT, Wang JY. Actinobacillus actinomycetemcomitans pneumonia with chest wall and subphrenic abscess. Scand J Infect Dis. 1995;27:289\u201390.","journal-title":"Scand J Infect Dis"},{"key":"2983_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/clinids\/11.1.46","volume":"11","author":"AH Kaplan","year":"1989","unstructured":"Kaplan AH, Weber DJ, Oddone EZ, Perfect JR. Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review. Rev Infect Dis. 1989;11:46\u201363.","journal-title":"Rev Infect Dis"},{"key":"2983_CR57","doi-asserted-by":"publisher","first-page":"23990","DOI":"10.3402\/jom.v6.23990","volume":"6","author":"L Abusleme","year":"2014","unstructured":"Abusleme L, Hong B-Y, Dupuy AK, Strausbaugh LD, Diaz PI. Influence of DNA extraction on oral microbial profiles obtained via 16S rRNA gene sequencing. J Oral Microbiol. 2014;6:23990.","journal-title":"J Oral Microbiol"},{"issue":"6","key":"2983_CR58","first-page":"1","volume":"61","author":"YS Bukin","year":"2019","unstructured":"Bukin YS, et al. The effect of 16S rRNA region choice on bacterial community metabarcoding results. Sci Data 2019. 2019;61(6):1\u201314.","journal-title":"Sci Data 2019"},{"key":"2983_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40168-015-0110-9","volume":"3","author":"W Zheng","year":"2015","unstructured":"Zheng W, et al. An accurate and efficient experimental approach for characterization of the complex oral microbiota. Microbiome. 2015;3:48.","journal-title":"Microbiome"},{"key":"2983_CR60","doi-asserted-by":"publisher","unstructured":"Ceccarani C, Severgnini MA, comparison between Greengenes. SILVA, RDP, and NCBI reference databases in four published microbiota datasets. bioRxiv 2023.04.12.535864 (2023) https:\/\/doi.org\/10.1101\/2023.04.12.535864","DOI":"10.1101\/2023.04.12.535864"},{"key":"2983_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.trsl.2012.02.005","volume":"160","author":"JM Beck","year":"2012","unstructured":"Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160:258\u201366.","journal-title":"Transl Res"},{"key":"2983_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/JCM.01650-10","volume":"49","author":"FA Stressmann","year":"2011","unstructured":"Stressmann FA, et al. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol. 2011;49:281\u201391.","journal-title":"J Clin Microbiol"},{"key":"2983_CR63","doi-asserted-by":"crossref","unstructured":"Patas K, Douros K, Priftis KN, Ioannidis A, Nikolaou C, Chatzipanagiotou S. Isolation of Aggregatibacter aphrophilus from bronchoalveolar lavage in a paediatric patient presenting with haemoptysis. New Microbes New Infect. 2019;29:100509.","DOI":"10.1016\/j.nmni.2019.01.005"},{"key":"2983_CR64","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2666-5247(21)00035-5","volume":"2","author":"MY Ramsheh","year":"2021","unstructured":"Ramsheh MY, et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe. 2021;2:e300\u201310.","journal-title":"Lancet Microbe"},{"key":"2983_CR65","doi-asserted-by":"publisher","first-page":"001329","DOI":"10.1099\/jmm.0.001329","volume":"70","author":"S Myers","year":"2021","unstructured":"Myers S, et al. Immunomodulatory streptococci that inhibit CXCL8 secretion and NF\u03baB activation are common members of the oral microbiota. J Med Microbiol. 2021;70:001329.","journal-title":"J Med Microbiol"},{"key":"2983_CR66","doi-asserted-by":"crossref","unstructured":"Bhagirath AY, Li Y, Somayajula D, Dadashi M, Badr S, Duan K.. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm Med. 2016;16:1\u201322.","DOI":"10.1186\/s12890-016-0339-5"},{"key":"2983_CR67","doi-asserted-by":"crossref","unstructured":"Cowley ES, Kopf SH, Lariviere A, Ziebis W, Newman DK. Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation. MBio 6, (2015).","DOI":"10.1128\/mBio.00767-15"},{"key":"2983_CR68","doi-asserted-by":"publisher","first-page":"1549931","DOI":"10.1080\/20002297.2018.1549931","volume":"11","author":"T Ahlstrand","year":"2019","unstructured":"Ahlstrand T, Kovesjoki L, Maula T, Oscarsson J, Ihalin R. Aggregatibacter actinomycetemcomitans LPS binds human interleukin-8. J Oral Microbiol. 2019;11:1549931.","journal-title":"J Oral Microbiol"},{"key":"2983_CR69","doi-asserted-by":"publisher","first-page":"557","DOI":"10.12688\/f1000research.18411.1","volume":"8","author":"AE Jasper","year":"2019","unstructured":"Jasper AE, McIver WJ, Sapey E, Walton GM. Understanding the role of neutrophils in chronic inflammatory airway disease. F1000Research. 2019;8:557.","journal-title":"F1000Research"},{"key":"2983_CR70","doi-asserted-by":"crossref","unstructured":"Moriel DG, Heras B, Paxman JJ, Lo AW, Tan L, Sullivan  MJ, et al. Molecular and structural characterization of a novel Escherichia coli interleukin receptor mimic protein. mBio. 2016;7:e02046.","DOI":"10.1128\/mBio.02046-15"},{"key":"2983_CR71","doi-asserted-by":"crossref","unstructured":"Grassi L, et al. Recreating chronic respiratory infections in vitro using physiologically relevant models. Eur Respir Rev. 2024;33.","DOI":"10.1183\/16000617.0062-2024"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02983-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02983-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T17:02:15Z","timestamp":1728752535000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02983-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02983-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Aus-asthma cohort received ethics approval ACTRN12609000197235 (registration date 20\/04\/2009) by the Hunter New England human research ethics committee. The Aus-bx cohort received ethics approval ACTRN12608000460303 (registration date 14\/07\/2009) by the Mater Health Service human research ethics committee. The Scot-bx cohort received ethics approval 12\/ES\/0059 by the East of Scotland Research Ethics committee. For Aus-asthma, the Human ethics and consent to participate was provided by the Hunter New England human research ethics committee. For Aus-bx, the Human ethics and consent to participate was provided by the Mater Health Service human research ethics committee. For Scot-bx, patients gave written informed consent and the study was approved by the East of Scotland Research Ethics committee (12\/ES\/0059).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"368"}}